Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Company News

Management tracks

April 28, 2016 1:12 AM UTC

Cancer company ImmunoGen Inc. (NASDAQ:IMGN) hired Mark Enyedy as president, CEO and a director, effective May 16. Enyedy was EVP and head of corporate development at Shire plc (LSE:SHP; NASDAQ:SHPG). He replaces Daniel Junius, who will retire as president and CEO while remaining a director.

Molecular diagnostic company Trovagene Inc. (NASDAQ:TROV) hired William Welch as CEO and said chief commercial officer Matthew Posard departed. Welch was president and CEO of Sequenom Inc. (NASDAQ:SQNM). ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article